{"id":128559,"date":"2022-04-21T08:33:47","date_gmt":"2022-04-21T12:33:47","guid":{"rendered":"https:\/\/44.250.171.167\/?p=128559"},"modified":"2022-10-05T06:34:55","modified_gmt":"2022-10-05T10:34:55","slug":"glenmark-life-sciences-limited-q4-fy22-earnings-conference-call-summary","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/glenmark-life-sciences-limited-q4-fy22-earnings-conference-call-summary\/","title":{"rendered":"Glenmark Life Sciences Limited Q4 FY22 Earnings Conference Call Summary"},"content":{"rendered":"<p><iframe loading=\"lazy\" title=\"Glenmark Life Sciences Limited Q4 FY22 Earnings Concall\" width=\"500\" height=\"375\" src=\"https:\/\/www.youtube.com\/embed\/au71QUL41tY?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<p><strong>Key highlights from Glenmark Life Sciences Limited (<a href=\"https:\/\/44.250.171.167\/symbol\/GLS\/\">GLS<\/a>) Q4 FY22 Earnings Concall<\/strong><\/p>\n<p><strong>Q&amp;A Highlights:<\/strong><\/p>\n<ul>\n<li>Neha Manpuria of Bank of America asked if GLS is seeing any issues relative to sourcing of raw materials due to lockdown in China. Yasir Rawjee MD said that the crisis is unlikely to impact the company unless it stretches for 2 months. GLS is looking at mitigating the situation through shipments from other ports.<\/li>\n<\/ul>\n<ul>\n<li>Neha Manpuria from Bank of America also asked that on the margins, does the company see incremental drift in margins in the next two quarters. Yasir Rawjee MD said that GLS has already built in and factored in some of the increases. GLS expects to continue to maintain margins at similar levels of 3Q and 4Q.<\/li>\n<\/ul>\n<ul>\n<li>Neha Manpuria \u00a0of Bank of America also asked if GLS is on track with the capex timelines and when can the backward integration be seen. Yasir Rawjee MD answered that BI will come in Sept., which is the one at Ankleshwar, while Dahej will come sooner, probably Phase 1 in July.<\/li>\n<\/ul>\n<ul>\n<li>Shyam Srinivasan with Goldman Sachs asked about the quantitative guidance on the revenue growth for FY23. \u00a0Yasir Rawjee MD said that the company considers between 12-14% growth on an overall basis.<\/li>\n<\/ul>\n<ul>\n<li>Vikas Sharda from NTAsset asked about margins and incrementally how the cost pressure is on the raw material side and other expenses. Yasir Rawjee MD said the only big question mark today for GLS is about gas prices. The company added that if the gas prices continue to rise, there could be some impact in 1H23.<\/li>\n<\/ul>\n<ul>\n<li>Tushar Manudhane from Motilal Oswal asked about the EBITDA margins for CDMO and API business. Bhavesh Pujara CFO answered that the company doesn\u2019t quantify it. But directionally the margins for CDMO are considerably higher than the margins in generic business.<\/li>\n<\/ul>\n<ul>\n<li>Rahul G of Abakkus Asset Manager asked that in FY22, of the INR2,100 crore of topline, including CDMO, how much of that will be COVID or COVID related ancillary products. Bhavesh Pujara CFO replied that about 7% was the contribution in FY21 and in FY22 it was less than 5%.<\/li>\n<\/ul>\n<ul>\n<li>Rupesh Tatiya from Intelsense Capital enquired that what kind of margin expansion GLS expects in 2-3 years from backward integration in Ankleshwar. Yasir Rawjee MD replied that the company expects margin expansion to the tune of 80-100 bps. In terms of ROCE, it will help GLS maintain or increase the ROCE levels.<\/li>\n<\/ul>\n<ul>\n<li>Saion Mukherjee with Nomura asked about the factor of price increase, volume of existing products and new launches in the 12-14% growth. Yasir Rawjee MD replied that it\u2019s a mix of price and volume, but largely coming from volume.<\/li>\n<\/ul>\n<ul>\n<li>\u00a0Saion Mukherjee with Nomura asked about the sale to Glenmark for 4Q22 and FY22. Yasir Rawjee MD said that for 4Q22 it could be around 36-37% and full year would be around 39-40%.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Key highlights from Glenmark Life Sciences Limited (GLS) Q4 FY22 Earnings Concall Q&amp;A Highlights: Neha Manpuria of Bank of America asked if GLS is seeing any issues relative to sourcing of raw materials due to lockdown in China. Yasir Rawjee MD said that the crisis is unlikely to impact the company unless it stretches for [&hellip;]<\/p>\n","protected":false},"author":1767,"featured_media":125416,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[9825,392,5747],"tags":[8157,1115],"class_list":["post-128559","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-earnings-call-highlights","category-earnings","category-healthcare-stocks","tag-healthcare","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":132675,"url":"https:\/\/alphastreet.com\/india\/glenmark-life-sciences-limited-q1-fy23-earnings-conference-call-insights\/","url_meta":{"origin":128559,"position":0},"title":"Glenmark Life Sciences Limited Q1 FY23 Earnings Conference Call Insights","author":"Praveen","date":"August 9, 2022","format":false,"excerpt":"https:\/\/youtu.be\/02Igs_HUAfo Key highlights from Glenmark Life Sciences Limited (GLS) Q1 FY23 Earnings Concall Q&A Highlights: [00:14:56] Neha Manpuria from Bank of America asked about the generic API business, ex-COVID growth, how much of the growth is volume vs. pricing that has flown through. Yasir Rawjee MD replied that the growth\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":135226,"url":"https:\/\/alphastreet.com\/india\/glenmark-life-sciences-limited-q2-fy23-earnings-conference-call-insights\/","url_meta":{"origin":128559,"position":1},"title":"Glenmark Life Sciences Limited Q2 FY23 Earnings Conference Call Insights","author":"Praveen","date":"October 27, 2022","format":false,"excerpt":"https:\/\/youtu.be\/FHgUfHa30gw Key highlights from Glenmark Life Sciences Limited (GLS) Q2 FY23 Earnings Concall Management Update: [00:02:53] GLS said that the demand softness did not impact its business significantly due to the mid-volume and high-value products it offers. Q&A Highlights: [00:14:51] Neha Manpuria from Bank of America asked about the generic\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":139447,"url":"https:\/\/alphastreet.com\/india\/glenmark-life-sciences-limited-q3-fy23-earnings-conference-call-insights\/","url_meta":{"origin":128559,"position":2},"title":"Glenmark Life Sciences Limited Q3 FY23 Earnings Conference Call Insights","author":"Praveen","date":"January 30, 2023","format":false,"excerpt":"Key highlights from Glenmark Life Sciences Limited (GLS) Q3 FY23 Earnings Concall Q&A Highlights: [00:13:44] Tarang Agrawal of Old Bridge enquired about the fixed cost accretion expectation on the P&L from 1Q24, given the Ankaleshwar and Dahej ramping up. Tushar Mistry CFO replied that on a QonQ basis, there should\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":144576,"url":"https:\/\/alphastreet.com\/india\/glenmark-life-sciences-limited-gls-q4-fy23-earnings-concall-transcript\/","url_meta":{"origin":128559,"position":3},"title":"Glenmark Life Sciences Limited (GLS) Q4 FY23 Earnings Concall Transcript","author":"IRS_INDIA","date":"April 28, 2023","format":false,"excerpt":"Glenmark Life Sciences Limited (NSE:GLS) Q4 FY23 Earnings Concall dated Apr. 28, 2023. Corporate Participants: Soumi Rao\u00a0--\u00a0General Manager, Corporate Communications Yasir Rawjee\u00a0--\u00a0Managing Director and Chief Executive Officer Tushar Mistry\u00a0--\u00a0Chief Financial Officer Unidentified Speaker\u00a0-- Analysts: Tarang Agarwal\u00a0--\u00a0Old Bridge Capital -- Analyst Neha Manpuria\u00a0--\u00a0Bank of America -- Analyst Madhusudan Kela\u00a0--\u00a0MK Ventures --\u2026","rel":"","context":"In &quot;Earnings Call Transcripts&quot;","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"Earnings Conference Call Transcript","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":136448,"url":"https:\/\/alphastreet.com\/india\/glenmark-life-sciences-limited-gls-q2-fy23-earnings-concall-transcript\/","url_meta":{"origin":128559,"position":4},"title":"Glenmark Life Sciences Limited (GLS) Q2 FY23 Earnings Concall Transcript","author":"IRS_INDIA","date":"October 21, 2022","format":false,"excerpt":"Glenmark Life Sciences Limited (NSE:GLS) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Soumi Rao -- Head - Corporate Communications Yasir Rawjee -- Managing Director and Chief Executive Officer Tushar Mistry -- Chief Financial Officer & Senior Vice President Analysts: Neha Manpuria -- Bank of America -- Analyst\u2026","rel":"","context":"In &quot;Earnings Call Transcripts&quot;","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"Earnings Conference Call Transcript","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":130453,"url":"https:\/\/alphastreet.com\/india\/glenmark-pharmaceuticals-limited-q4-fy22-earnings-conference-call-insights\/","url_meta":{"origin":128559,"position":5},"title":"Glenmark Pharmaceuticals Limited Q4 FY22 Earnings Conference Call Insights","author":"Praveen","date":"June 2, 2022","format":false,"excerpt":"https:\/\/youtu.be\/uTUQ9VpSoiU Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q4 FY22 Earnings Concall Management Update: GLENMARK said the India business continues to significantly outperform industry growth rates, continuing the trend of the past several years. The company said it filed a total of 19 ANDA applications with the U.S. FDA in\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/128559","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1767"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=128559"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/128559\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/125416"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=128559"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=128559"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=128559"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}